BrainCapture
BrainCapture is a Danish healthtech company that builds and sells the BC-1, a portable CE MDR-certified EEG system paired with a cloud-based remote specialist reading service, enabling non-specialist healthcare workers in hospitals and resource-limited facilities to perform point-of-care neurological diagnostics.
- Company typePrivate
- Founded2019
- HeadquartersKongens Lyngby, Denmark
- Headcount1–10
- GTM typeB2B
- OfferingHardware or Manufacturing
What BrainCapture does
BrainCapture ApS is a Danish healthtech company founded in 2019 and headquartered at DTU Science Park in Kongens Lyngby, Denmark. It develops and sells the BC-1, a portable 32-channel EEG system designed to make neurological diagnostics accessible at the point of care, particularly in settings without on-site neurologists. The integrated solution combines a battery-powered CE MDR-certified amplifier, a mobile application that automates the standard EEG exam workflow, a HIPAA/GDPR-compliant cloud platform for remote reading, and five sizes of electrode caps engineered for correct placement by non-specialist staff.
The company's commercial model combines hardware sales of the BC-1 system with a recurring Expertise-as-a-Service layer that routes captured EEG data to remote neurological specialists for interpretation and reporting. Go-to-market is consultative enterprise sales ("Request a Demo") targeting acute care (ICU, post-cardiac arrest, TBI, stroke, NCSE rule-out), outpatient neurology, and resource-limited healthcare facilities. As of 2024, BrainCapture reports deployment across 15+ countries and six continents, with CE MDR certification for acute/critical care, and has secured investment from Verge HealthTech Fund plus co-funding from the European Innovation Council.
BrainCapture firmographics
Firmographics- Name
- BrainCapture
- Legal name
- BrainCapture ApS
- Website
- https://braincapture.dk
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BrainCapture is a Danish healthtech company that builds and sells the BC-1, a portable CE MDR-certified EEG system paired with a cloud-based remote specialist reading service, enabling non-specialist healthcare workers in hospitals and resource-limited facilities to perform point-of-care neurological diagnostics.
- Ownership category
- akta.pro rank
BrainCapture industry classification
Industry- Product category
- Medical EEG Devices
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Instruments For Meas & Testing Of Electricity & Elec Signals (3825)
- akta.pro primary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
- akta.pro secondary industries
- Neurology RPM (epilepsy, Parkinson’s, MS monitoring) (HLALAFAJ), Neurology Telemedicine Platforms (HLALAGAC), Medical-Grade Device Connectivity & Device Management (MDM) (HLACAFAG)
Keywords
Where BrainCapture is headquartered
LocationHeadquarters
- HQ city
- Kongens Lyngby
- HQ country
- Denmark
- HQ region
- Europe
Offices1 record
Markets served
BrainCapture business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- BC-1 EEG Hardware System: Sale of portable EEG hardware including the amplifier, electrode caps, and mobile application components.
- Cloud-Based EEG Reading Service: Expertise-as-a-Service model providing access to remote neurological specialists for rapid, clinical-grade interpretation and reporting via the BrainCapture EEG analysis platform. This is a recurring service component.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
BrainCapture product offering
Product offeringCore offering
BrainCapture designs, manufactures, and sells the BC-1, a portable, battery-powered EEG system comprising a 32-channel CE MDR-certified amplifier, an automated mobile application, electrode caps in five sizes, and a cloud-based platform for remote interpretation. The solution enables non-specialist healthcare workers to collect high-quality EEG data at the point of care and have it read remotely by neurological specialists.
Product overview
BrainCapture offers the BC-1 integrated EEG solution consisting of four key components: a portable BC-1 amplifier (CE MDR certified), a mobile application that automates the EEG exam workflow, a cloud-based platform for remote specialist interpretation and reporting, and electrode caps in 5 sizes. The system is designed for point-of-care deployment in resource-limited settings, enabling non-specialist healthcare workers to collect high-quality EEG data after minimal training, with remote experts providing interpretation via the cloud platform. The solution supports both routine outpatient use and acute/critical care settings.
Differentiator
Problem solved
Functional benefit
Brands
- BC-1: Portable EEG system consisting of amplifier, application, cloud platform, and electrode caps for point-of-care neurological diagnostics
Products and services
- BC-1 EEG System The BC-1 is an integrated portable, battery-powered EEG system consisting of a 32-channel CE MDR-certified amplifier (256 Hz sampling rate, 24-hour battery, IP22 rating, zero calibration required), an automated mobile application, a GDPR/HIPAA-compliant cloud platform, and electrode caps in five sizes fitting children from 8 months to adulthood. It is designed to make neurological diagnostics accessible at the point of care across outpatient clinics, general hospitals, ICUs, and acute care departments.
- Expertise-as-a-Service (Remote EEG Interpretation) A recurring service providing access to BrainCapture's network of remote neurological specialists for rapid, clinical-grade interpretation and reporting of EEG data via the BrainCapture cloud platform, enabling 24/7 expert reading without dependence on in-house specialist availability.
Quantifiable outcome
- 30% of ICU patients are at high risk for non-convulsive seizures (NCS), which are invisible and can cause severe brain injury
- +3 more outcomes
Companies that use BrainCapture
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles2 records
BrainCapture technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability4 records
Feature5 records
BrainCapture partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights6 records
BrainCapture competitors and assessment
Company assessmentDirect peers
- ANT Neuro: ANT Neuro produces EEG amplifiers (eego, WaveGuard caps) and software for clinical and research neurophysiology — directly overlapping with BrainCapture's amplifier + electrode cap + cloud platform stack.
- Ceribell: Ceribell makes a point-of-care EEG system (Ceribell Rapid Response) and cloud-based AI seizure detection (Clarity) targeted at non-specialist hospital staff — directly analogous to BrainCapture's hardware + cloud + remote-expert model for non-EEG-trained clinicians.
- Compumedics: Compumedics is a long-standing EEG and sleep diagnostic hardware manufacturer selling amplifiers, software, and cloud platforms to hospitals and research centers — a direct competitor in clinical EEG with established global distribution.
Emerging players
- Emotiv: Emotiv makes consumer and research-grade EEG headsets (EPOC, Insight) with cloud APIs. It is not a clinical competitor today but represents the longer-term direction of low-cost, mobile, cloud-connected EEG that BrainCapture also targets in resource-limited settings.
- Wave Neuroscience: Wave Neuroscience applies EEG-based assessment and neurofeedback/therapy in clinical settings. It is adjacent rather than head-to-head, but competes for the same neurology customer budgets and EEG-clinical positioning.
- Zeto: Zeto offers a wireless EEG headset with cloud-based review and AI-assisted analysis for clinical and research use, targeting easier EEG at the point of care — directly comparable to BrainCapture's portable hardware + cloud + automated workflow approach.
- Epitel: Epitel develops wearable, wireless EEG sensors (REMI) for continuous seizure monitoring in ambulatory and inpatient settings. It overlaps with BrainCapture on the EEG wearable and seizure-detection use case but emphasizes long-term monitoring rather than point-of-care diagnostic EEG.
- CGX (Quick-20 / Cognionics): CGX (formerly Cognionics) builds dry-electrode, wireless EEG headsets (Quick-20) for clinical and research use. It competes with BrainCapture on portable, easy-to-apply EEG hardware but has less of an integrated remote-interpretation service.
Broad incumbents
- Natus Medical: Natus is a broad incumbent in neurodiagnostic equipment (EEG, EMG, PSG) with deep hospital channel relationships. It does not focus exclusively on point-of-care EEG but its installed base and service network define the competitive backdrop for any EEG hardware entrant.
- Cadwell Industries: Cadwell manufactures EEG, EMG, and intraoperative monitoring systems sold to hospitals and neurology practices. It is a broad neurodiagnostic incumbent whose product portfolio and US sales channel overlap with BrainCapture's addressable market.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
BrainCapture social profiles
Digital presenceBrainCapture compliance and trust
Trust signalCompliance1 record
BrainCapture financial estimates
Financial estimateRevenue estimate
Valuation estimate
BrainCapture leadership team
Management profileNumber of profiles
Profiles2 records
BrainCapture funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BrainCapture M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BrainCapture
What does BrainCapture do?
BrainCapture designs, manufactures, and sells the BC-1, a portable, battery-powered EEG system comprising a 32-channel CE MDR-certified amplifier, an automated mobile application, electrode caps in five sizes, and a cloud-based platform for remote interpretation. The solution enables non-specialist healthcare workers to collect high-quality EEG data at the point of care and have it read remotely by neurological specialists.
Is BrainCapture a public or private company?
BrainCapture is a private company. It is classified as venture growth investor backed and is currently operating.
When was BrainCapture founded?
BrainCapture was founded in 2019. It employs 1 to 10 people.
Where is BrainCapture based?
BrainCapture is headquartered in Kongens Lyngby, Denmark, in the Europe region.
How does BrainCapture make money?
Two revenue lines are on record. BC-1 EEG Hardware System is the primary driver. The others are cloud-Based EEG Reading Service.
Who are BrainCapture's main competitors?
Direct peers on record are ANT Neuro, Ceribell and Compumedics. Emerging players are Emotiv, Wave Neuroscience, Zeto, Epitel and CGX (Quick-20 / Cognionics). Broad incumbents are Natus Medical and Cadwell Industries.
Does BrainCapture have an API?
No public API is recorded for BrainCapture.
What industry is BrainCapture in?
BrainCapture's product category is Medical EEG Devices. Its primary akta.pro industry code is HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables), with a secondary code of HLALAFAJ, Neurology RPM (epilepsy, Parkinson’s, MS monitoring). Its NAICS code is 334510 and its SIC code is 3845.